Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
7,875
Price
$474.65
Total Value
$3.74M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
14,625
Price
$474.65
Total Value
$6.94M
Shares Held After
0
% of Holdings
100.0%
ACADIA PHARMACEUTICALS INC (ACAD)
Rhodes Jennifer J — EVP, CHIEF LEGAL OFFICER, SEC
Shares
6,950
Price
$23.38
Total Value
$162.49K
Shares Held After
7,609
% of Holdings
47.7%
SpyGlass Pharma, Inc. Common Stock (SGP)
Vensana Capital I GP, LLC — 10% Owner
Shares
165,000
Price
$16.00
Total Value
$2.64M
Shares Held After
3,310,619
% of Holdings
5.0%
SpyGlass Pharma, Inc. Common Stock (SGP)
Nielsen Kirk G. — Director
Shares
165,000
Price
$16.00
Total Value
$2.64M
Shares Held After
3,310,619
% of Holdings
5.0%
ZEVRA THERAPEUTICS, INC. (ZVRA)
McFarlane Neil F. — Director
Shares
14,625
Price
$8.56
Total Value
$125.19K
Shares Held After
387,225
% of Holdings
3.6%
Syndax Pharmaceuticals, Inc. (SNDX)
Metzger Michael A — Director
Shares
17,159
Price
$21.03
Total Value
$360.82K
Shares Held After
491,690
% of Holdings
3.4%
Syndax Pharmaceuticals, Inc. (SNDX)
Goldan Keith A. — Chief Financial Officer
Shares
3,410
Price
$21.03
Total Value
$71.71K
Shares Held After
140,429
% of Holdings
2.4%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
14,261
Price
$16.66
Total Value
$237.62K
Shares Held After
42,749
% of Holdings
25.0%
Zentalis Pharmaceuticals, Inc. (ZNTL)
EASTLAND JULIA MARIE — Director
Shares
7,866
Price
$2.43
Total Value
$19.11K
Shares Held After
80,022
% of Holdings
9.0%
Zentalis Pharmaceuticals, Inc. (ZNTL)
Bruns Ingmar — Chief Medical Officer
Shares
2,962
Price
$2.43
Total Value
$7.20K
Shares Held After
33,667
% of Holdings
8.1%
Zentalis Pharmaceuticals, Inc. (ZNTL)
Vultaggio Vincent — PAO and PFO
Shares
29,951
Price
$2.43
Total Value
$72.77K
Shares Held After
156,779
% of Holdings
16.0%
Cingulate Inc. (CING)
Brams Matthew — EVP and Chief Medical Officer
Shares
1,946
Price
$5.04
Total Value
$9.81K
Shares Held After
4,656
% of Holdings
41.8%
Cingulate Inc. (CING)
Schaffer Shane J. — Director
Shares
6,809
Price
$5.04
Total Value
$34.32K
Shares Held After
10,175
% of Holdings
66.9%
Cingulate Inc. (CING)
Callahan Jennifer L. — SVP and CFO
Shares
4,864
Price
$5.04
Total Value
$24.51K
Shares Held After
5,059
% of Holdings
96.1%
Cingulate Inc. (CING)
Werth Peter J. — Director
Shares
19,455
Price
$5.04
Total Value
$98.05K
Shares Held After
117,449
% of Holdings
16.6%
Enliven Therapeutics, Inc. (ELVN)
Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Shares
5,000
Price
$29.04
Total Value
$145.22K
Shares Held After
740,188
% of Holdings
0.7%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
29,430
Price
$85.79
Total Value
$2.52M
Shares Held After
254,497
% of Holdings
10.4%
Spero Therapeutics, Inc. (SPRO)
Keutzer Timothy — Chief Operating Officer
Shares
18,652
Price
$2.36
Total Value
$44.02K
Shares Held After
742,506
% of Holdings
2.5%
Spero Therapeutics, Inc. (SPRO)
Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Shares
50,816
Price
$2.36
Total Value
$119.93K
Shares Held After
1,012,091
% of Holdings
4.8%
Spero Therapeutics, Inc. (SPRO)
Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Shares
37,101
Price
$2.36
Total Value
$87.56K
Shares Held After
1,062,907
% of Holdings
3.4%
CODEXIS, INC. (CDXS)
MOORE ALISON — Director
Shares
3,826
Price
$1.31
Total Value
$5.00K
Shares Held After
250,506
% of Holdings
1.5%
CODEXIS, INC. (CDXS)
Erbez Georgia — Chief Financial Officer and Chief Business Officer
Shares
3,826
Price
$1.31
Total Value
$5.00K
Shares Held After
66,810
% of Holdings
5.4%
CODEXIS, INC. (CDXS)
Lutz Stefan — Chief Scientific Officer
Shares
2,492
Price
$1.31
Total Value
$3.26K
Shares Held After
136,283
% of Holdings
1.8%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
50,000
Price
$0.95
Total Value
$47.28K
Shares Held After
1,888,551
% of Holdings
2.6%
GALECTIN THERAPEUTICS INC (GALT)
ELDRED KARY — Director
Shares
300
Price
$2.70
Total Value
$810.00
Shares Held After
65,682
% of Holdings
0.5%
Syndax Pharmaceuticals, Inc. (SNDX)
Goldan Keith A. — Chief Financial Officer
Shares
2,082
Price
$20.62
Total Value
$42.93K
Shares Held After
143,839
% of Holdings
1.4%
Syndax Pharmaceuticals, Inc. (SNDX)
Metzger Michael A — Director
Shares
7,412
Price
$20.62
Total Value
$152.84K
Shares Held After
508,849
% of Holdings
1.4%
Protagonist Therapeutics, Inc. (PTGX)
Waddill William D. — Director
Shares
20,000
Price
$83.68
Total Value
$1.67M
Shares Held After
7,825
% of Holdings
71.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
3,381
Price
$106.06
Total Value
$358.60K
Shares Held After
125,537
% of Holdings
2.6%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
869
Price
$152.44
Total Value
$132.47K
Shares Held After
83,243
% of Holdings
1.0%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
15,000
Price
$61.93
Total Value
$928.95K
Shares Held After
50,440
% of Holdings
22.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,624
Price
$78.94
Total Value
$365.00K
Shares Held After
708,719
% of Holdings
0.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,376
Price
$78.38
Total Value
$421.37K
Shares Held After
713,343
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
675
Price
$485.52
Total Value
$327.72K
Shares Held After
36,781
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
934
Price
$484.92
Total Value
$452.91K
Shares Held After
37,456
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,748
Price
$483.92
Total Value
$1.33M
Shares Held After
38,390
% of Holdings
6.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,103
Price
$482.57
Total Value
$532.27K
Shares Held After
41,138
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,363
Price
$481.93
Total Value
$1.14M
Shares Held After
42,241
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
477
Price
$480.92
Total Value
$229.40K
Shares Held After
44,604
% of Holdings
1.1%
Adaptive Biotechnologies Corp (ADPT)
PISKEL KYLE — Chief Financial Officer
Shares
2,145
Price
$18.46
Total Value
$39.60K
Shares Held After
216,637
% of Holdings
1.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
747
Price
$107.67
Total Value
$80.43K
Shares Held After
128,918
% of Holdings
0.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,000
Price
$106.60
Total Value
$106.60K
Shares Held After
129,665
% of Holdings
0.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,500
Price
$104.74
Total Value
$157.12K
Shares Held After
130,665
% of Holdings
1.1%
Solid Biosciences Inc. (SLDB)
Brooks Gabriel — Chief Medical Officer
Shares
12,616
Price
$6.44
Total Value
$81.27K
Shares Held After
84,092
% of Holdings
13.0%
Solid Biosciences Inc. (SLDB)
Tan Kevin — CFO & Treasurer
Shares
14,783
Price
$6.44
Total Value
$95.23K
Shares Held After
94,201
% of Holdings
13.6%
Solid Biosciences Inc. (SLDB)
Ganot Ilan — Director
Shares
7,205
Price
$6.44
Total Value
$46.41K
Shares Held After
25,271
% of Holdings
22.2%
Solid Biosciences Inc. (SLDB)
Howton David T — Chief Operating Officer
Shares
18,894
Price
$6.44
Total Value
$121.71K
Shares Held After
97,859
% of Holdings
16.2%
Solid Biosciences Inc. (SLDB)
Cumbo Alexander — Director
Shares
48,913
Price
$6.44
Total Value
$315.09K
Shares Held After
222,018
% of Holdings
18.1%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$4.12
Total Value
$164.80K
Shares Held After
913,839
% of Holdings
4.2%
Showing 701–750 of 936 transactions (page 15 of 19)